Zigu-glucoside I
CAS No. 35286-58-9
Zigu-glucoside I( —— )
Catalog No. M18466 CAS No. 35286-58-9
Ziyuglycoside I has anti-inflammatory activity, could be used as an active ingredient for cosmetics.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 83 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 304 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZigu-glucoside I
-
NoteResearch use only, not for human use.
-
Brief DescriptionZiyuglycoside I has anti-inflammatory activity, could be used as an active ingredient for cosmetics.
-
DescriptionZiyuglycoside I has anti-inflammatory activity, could be used as an active ingredient for cosmetics.
-
In VitroZiyuglycoside I (5-160 μM; 24 hours) reveals a marked anti-proliferation activity with an IC50 value of 13.96 μM in MDA-MB-231 cells.Ziyuglycoside I (5-20 μM; 24 hours) induces MDA-MB-231 cell apoptosis by increasing the percentage of apoptotic cells from 2.43% to 44.76% at 20 μM.Ziyuglycoside I (5-20 μM; 24 hours) induces the cleavage of caspas-8, caspase-9, and caspase-3, up-regulates the pro-apoptotic protein Bax, and down-regulates anti-apoptotic protein Bal-2, dose-dependently reduces the level of mito-cyto c expression. Cell Viability Assay Cell Line:MDA-MB-231 cells Concentration:5 μM, 10 μM, 20 μM, 40 μM, 80 μM, and 160 μM Incubation Time:24 hours Result:Showed cytotoxicity on MDA-MB-231 cells.Cell Cycle Analysis Cell Line:MDA-MB-231 cells Concentration:5 μM, 10 μM, and 20 μM Incubation Time:24 hours Result:Induced G2/M phase arrest and apoptosis on MDA-MB-231 CellsWestern Blot Analysis Cell Line:MDA-MB-231 cells Concentration:5 μM, 10 μM, and 20 μM Incubation Time:24 hours Result:Induced apoptosis in MDA-MB-231 Cells through Intrinsic and Extrinsic Pathways.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35286-58-9
-
Formula Weight766.97
-
Molecular FormulaC41H66O13
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Methanol : 125 mg/mL (162.98 )
-
SMILESC[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]3[C@@]4(CC[C@@H](C3(C)C)O[C@H]3[C@@H]([C@H]([C@H](CO3)O)O)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ye W,et al. Development and validation of a quantification method for ziyuglycoside I and II in rat plasma: Application to their pharmacokinetic studies. J Sep Sci. 2015 Jul;38(13):2340-7.
molnova catalog
related products
-
Docosane-1,22-diol
Docosane-1,22-diol (1,22-Docosanediol) is a long-chain fatty acid used in the synthesis of crystalline compounds.
-
Ethylenebis(oxyethyl...
Ethylene glycol?bis(2-aminoethyl)tetraacetic acid is a diether that is?ethylene glycol?in which the hydrogens of the?hydroxy?groups have been replaced by 2-[bis(carboxymethyl)amino]ethyl group respectively.
-
Bucetin
Bucetin is a pharmaceutical drug that acts as an analgesic and antipyretic.
Cart
sales@molnova.com